Все публикации

0:23:20

What is Colchicine Worth? (6.23.2023)

0:17:58

How Often Do You Monitor MTX (6.16.2023)

0:25:08

EULAR 2023 Notes from Milan

0:11:55

Still's Disease Abstracts at EULAR 2023

0:08:53

2023 EULAR/PReS Recommendations on Still's disease

0:22:28

New Thoughts on Long COVID from EULAR 2023

0:32:30

SLE Panel Review - EULAR 2023

0:04:27

Psoriatic Arthritis Guidelines (updated)

0:38:49

RA Panel Discussion from EULAR 2023

0:05:49

TLL-018 (a JAK1/TYK2 agent) vs. Tofacitinib in RA

0:04:35

Upadacitinib in SLE

0:06:39

Dazodalibep: A Glimmer of Hope in Sjogren's Syndrome?

0:35:56

EULAR 2023 Day 4 Recap

0:15:49

Assessment of Psoriatic Arthritis: A Global Perspective

0:02:13

CV Benefits with GLP 1 Receptor Agonists in Autoimmune Patients

0:06:36

Early Diagnosis of Axial Spondyloarthritis

0:04:30

Update on CAR T Cell Therapy in SLE & Autoimmune Diseases

0:43:33

Daily Recap: Day Three EULAR 2023

0:22:05

Artificial Intelligence in Rheumatology: Now and the Future

0:06:07

JAKpot or JAKnot

0:06:21

Should you Assess Rheumatoid Factor Serially?

0:12:21

De Novo Renal Nephritis Flares During Belimumab Trials

0:03:57

APIPPRA Study in Preclinical RA

0:04:26

The Importance of Knowing Which Entheses are Involved in PsA